{"id":"W2097741655","doi":"10.1016/j.crohns.2014.05.007","title":"Crohn's disease outpatients treated with adalimumab have an earlier secondary loss of response and requirement for dose escalation compared to infliximab: A real life cohort study","year":2014,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"University of Alberta; Alberta Innovates; Alberta Innovates - Health Solutions","keywords":"Medicine; Infliximab; Adalimumab; Crohn's disease; De-escalation; Cohort; Internal medicine; Inflammatory bowel disease; Disease","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000500711,0.0001473121,0.0002639728,0.00007907928,0.00008601829,0.0000481717,0.00008236913,0.00005038818,0.000007342111],"category_scores_gemma":[0.0001315741,0.0001235233,0.00005300449,0.00003202066,0.0000862974,0.00002532576,0.00004600188,0.00005078487,1.608906e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002432052,"about_ca_system_score_gemma":0.0002034633,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003589935,"about_ca_topic_score_gemma":0.000101873,"domain_scores_codex":[0.9987497,0.0002118398,0.0004300753,0.00021519,0.0002275909,0.0001656588],"domain_scores_gemma":[0.9985541,0.00002526204,0.0003014236,0.0002139361,0.0004357528,0.0004695207],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2110401,0.0005491968,0.7852231,0.00007459808,0.0002226765,0.0002463422,0.0005783082,0.00008709812,0.0007082081,0.00001949984,0.000191714,0.001059203],"study_design_scores_gemma":[0.005576903,0.003081728,0.9898686,0.00005204249,0.0001608861,0.000009873817,0.0002901144,0.0001551183,0.0002396166,0.00002055433,0.0003953879,0.0001491597],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9987687,0.00003777628,0.0001671299,0.00004395424,0.00003244647,0.0007970665,0.0001123473,0.000003008176,0.00003757502],"genre_scores_gemma":[0.9994584,0.00001390075,0.0001631169,0.0001211849,0.00008937913,0.00003847033,0.00002777727,0.00001912118,0.00006866793],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2054632,"threshold_uncertainty_score":0.5037134,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009976620233146105,"score_gpt":0.2623562512399987,"score_spread":0.2523796310068526,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}